Main information

  • Trade name:
  • Thompson's One-A-Day AstaMax
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug



  • Available in:
  • Thompson's One-A-Day AstaMax
  • Language:
  • English

Other information


  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 221922
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:


Thompson's One-A-Day AstaMax

ARTG entry for

Medicine Listed


Integria Healthcare Australia Pty Ltd

Postal Address



ARTG Start Date


Product category




Approval area

Listed Medicines


Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be


The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.


1. Thompson's One-A-Day AstaMax

Product Type

Single Medicine Product

Effective date

4/07/2017 9:45:55 AM


If symptoms persist consult your healthcare practitioner (or words to that effect).

Standard Indications

Maintenance of healthy eyes.

Eyes formula. Support of healthy eye function.

Eyes formula. Assists visual fatigue and eye-strain.

Aids, assists or helps in the maintenance of general well-being

Specific Indications

Helps to maintain immune function / Supports a healthy immune system

Helps reduce inflammation

Helps to inhibit inflammatory mediators in the body

Helps to protect the skin against oxidative damage caused by ultraviolet (UV) light

Helps to protect the skin against ultraviolet (UV) radiation from sunlight

Astaxanthin has a photoprotective effect

Helps improve the overall condition of the skin such as fine wrinkles, elasticity and moisture content

Astaxanthin has neuroprotective effects

Support healthy ageing of the skin by protecting cells from oxidative damage and ultraviolet radiation


An antioxidant or free radical scavenger

Astaxanthin helps to protect cell membranes against oxidation or free radical damage

Helps to decrease oxidation of lipids or fatty acids in the body

Astaxanthin has been shown to have greater antioxidant activity than vitamin E, lycopene, beta-carotene and lutein

Ultraviolet (UV) light from the sun is an important contributor to skin aging, such as the breakdown of collagen and the formation of fine wrinkles

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Public Summary

Page 1 of

Produced at 26.11.2017 at 12:22:13 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information


1. Formulation 1

Dosage Form

Capsule, soft

Route of Administration


Visual Identification

Active Ingredients

astaxanthin esters extracted from Haematococcus pluvialis

120 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at

Public Summary

Page 2 of

Produced at 26.11.2017 at 12:22:13 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information